Publications by authors named "Laird Miers"

Claim this Profile
C
Correction: Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle.
Peter Bannerman, Travis Burns, Jie Xu, Laird Miers, David Pleasure

PLoS One· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle.
Peter Bannerman, Travis Burns, Jie Xu, Laird Miers, David Pleasure

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressing N-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy.
Jiho Sohn, Peter Bannerman, Fuzheng Guo, Travis Burns, Laird Miers

J Neurosci· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis.
Monica A Moreno, Travis Burns, Pamela Yao, Laird Miers, David Pleasure

J Neuroimmunol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.
Fuzheng Guo, Peter Bannerman, Emily Mills Ko, Laird Miers, Jie Xu

Ann Neurol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE.
Monica Moreno, Peter Bannerman, Joyce Ma, Fuzheng Guo, Laird Miers

J Neurosci· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
Emily Mills Ko, Joyce H Ma, Fuzheng Guo, Laird Miers, Eunyoung Lee

J Neuroinflammation· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuronopathy in the motor neocortex in a chronic model of multiple sclerosis.
Travis Burns, Laird Miers, Jie Xu, Alan Man, Monica Moreno

J Neuropathol Exp Neurol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development.
Fuzheng Guo, Yoshiko Maeda, Emily Mills Ko, Monica Delgado, Makoto Horiuchi, Laird Miers

J Neurosci· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis.
Fuzheng Guo, Yoshiko Maeda, Joyce Ma, Monica Delgado, Jiho Sohn, Laird Miers

J Neurosci· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyramidal neurons are generated from oligodendroglial progenitor cells in adult piriform cortex.
Fuzheng Guo, Yoshiko Maeda, Joyce Ma, Jie Xu, Makoto Horiuchi, Laird Miers

J Neurosci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.
Athena M Soulika, Eunyoung Lee, Erica McCauley, Laird Miers, Peter Bannerman

J Neurosci· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma.
Gerald L DeNardo, Arutselvan Natarajan, Saphon Hok, Julie Perkins, Monique Cosman, Laird A Miers

J Nucl Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice.
Sally J DeNardo, Gerald L DeNardo, Arutselvan Natarajan, Laird A Miers, Allan R Foreman

J Nucl Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograft.
Laird Miers, Sally J DeNardo, Kathleen Lamborn, Gerald L DeNardo

Cancer Biother Radiopharm· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.
Sally J DeNardo, Gerald L DeNardo, Laird A Miers, Arutselvan Natarajan, Alan R Foreman

Clin Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers?
Laird Miers, Kathleen Lamborn, Aina Yuan, Carol Richman, Arutselvan Natarajan

Clin Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates.
Gerald L DeNardo, Sally J DeNardo, James J Peterson, Laird A Miers, Kit S Lam

Clin Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts.
Joseph M Tuscano, Robert T O'Donnell, Laird A Miers, Linda A Kroger, David L Kukis

Blood· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
Patricia A Burke, Sally J DeNardo, Laird A Miers, Kathleen R Lamborn, Siegfried Matzku

Cancer Res· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined modality radioimmunotherapy. Promise and peril.
Patricia A Burke, Sally J DeNardo, Laird A Miers, David L Kukis, Gerald L DeNardo

Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
Robert T O'Donnell, Sally J DeNardo, Laird A Miers, Kathleen R Lamborn, David L Kukis

Prostate· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis